Observational studyJCO clinical cancer informatics2026
Identification of Barriers to Digital Patient Portal Adoption Among Patients With Prostate Cancer Undergoing Curative Radiotherapy at a Canadian Provincial Cancer Program: A Quality Improvement Study.
Observational study in JCO clinical cancer informatics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
purposeDigital patient portals (DPPs) provide patients a direct electronic link with their care teams allowing secure, rapid symptom reporting and the capture of electronic patient-reported outcome questionnaires. A proportion of patients face barriers to DPP adoption. We conducted a prospective observational cohort study to quantify the proportion of DPP nonadopters and identify factors associated with DPP nonadoption.
methodsAll patients with prostate cancer undergoing radical radiotherapy at a Canadian Provincial Cancer Program were given the opportunity to install a DPP on their mobile device/tablet before starting radiotherapy. Each patient completed a self-reported questionnaire assessing their willingness and ability to use the DPP and quantified variables associated with their decision. A DPP adopter was defined as a patient who logged into the application and accessed their radiotherapy educational materials. Descriptive variables were tabulated by DPP adoption status. Differences in distributions of baseline characteristics were assessed using standard parametric and nonparametric statistics. Univariable and multivariable logistic regression analyses were performed to identify variables associated with DPP nonadoption.
resultsBetween July 2022 and January 2023, 118 patients with prostate cancer were enrolled with a median age of 71 years (range, 50-86). Most patients (56.8%) had a college diploma, 29.6% lived rurally, and 95.8% owned a smartphone. Twenty-eight patients (23.8%) were DPP nonadopters. On stepwise multivariable logistic regression analysis, poor self-reported ability to use mobile devices was associated with DPP nonadoption (
conclusionAmong patients with prostate cancer undergoing radical radiotherapy, poor self-reported ability to use smartphone technology was identified as the primary barrier to DPP adoption. Interventions geared at mitigating this barrier to DPP adoption are needed.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.